1115 Results (Page 6 of 45)
Medical Devices Markets Research Reports
Germany Pharmacy Automation Device Market Analysis
The Germany Pharmacy Automation Device Market was valued at $201.3 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $347.2 Mn by 2030. Germany Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Rising Medication Errors, Technological Advancements. The market is primarily dominated by players such as Swisslog Healthcare, Becton, Dickinson and Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation.
France Pharmacy Automation Device Market Analysis
The France Pharmacy Automation Device Market was valued at $151.2 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $274.7 Mn by 2030. France Pharmacy Automation Device Market is growing due to Growing Healthcare Expenses, Increased Medication Errors, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC.
Mexico Pharmacy Automation Device Market Analysis
The Mexico Pharmacy Automation Device Market was valued at $82.5 Mn in 2023 and is predicted to grow at a CAGR of 10.15% from 2023 to 2030, to $162.3 Mn by 2030. Mexico Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Rising Demand for Pharmaceuticals, Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter.
Brazil Pharmacy Automation Device Market Analysis
The Brazil Pharmacy Automation Device Market was valued at $137.5 Mn in 2023 and is predicted to grow at a CAGR of 10.9% from 2023 to 2030, to $283.7 Mn by 2030. Brazil Pharmacy Automation Device Market is growing due to Increasing Healthcare Expenditure, Adoption of Electronic Health Records, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter.
Saudi Arabia Pharmacy Automation Device Market Analysis
The Saudi Arabia Pharmacy Automation Device Market was valued at $93.5 Mn in 2023 and is predicted to grow at a CAGR of 11.4% from 2023 to 2030, to $199.1 Mn by 2030. Saudi Arabia Pharmacy Automation Device Market is growing due to Increasing Demand for Efficiency, Adoption of Electronic Health Records, Increasing adoption among end-users. The market is primarily dominated by players such as Becton Dickinson and Co, Capsa Solutions LLC, Omnicell Inc, Oracle Corp, Veradigm LLC, Swisslog Healthcare AG, McKesson Corporation.
US Pharmacy Automation Device Market Analysis
The US Pharmacy Automation Device Market was valued at $2310 Mn in 2023 and is predicted to grow at a CAGR of 7.9% from 2023 to 2030, to $3933.3 Mn by 2030. US Pharmacy Automation Device Market is growing due to Growing need to minimize medication errors, Rising Demand for Pharmaceuticals, and Increasing adoption among end-users. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC, Becton Dickinson and Company, Fulcrum Pharmacy Management, Inc.
Canada Pharmacy Automation Device Market Analysis
The Canada Pharmacy Automation Device Market was valued at $440 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $852 Mn by 2030. Canada Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Reducing Human Errors, and Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
India Cardiac Pacemakers Market Analysis
The India Cardiac Pacemakers Market was valued at $73.60 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $112.13 Mn by 2030. The key drivers of this industry include medical tourism, rising prevalence, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
South Africa Cardiac Pacemakers Market Analysis
The South Africa Cardiac Pacemakers Market was valued at $26.30 Mn in 2023 and is predicted to grow at a CAGR of 4.43% from 2023 to 2030, to $35.63 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular disease, the increasing aging population, and advancements in technology. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Kenya Cardiac Pacemakers Market Analysis
The Kenya Cardiac Pacemakers Market was valued at $2.83 Mn in 2023 and is predicted to grow at a CAGR of 4.3% from 2023 to 2030, to $3.80 Mn by 2030. The key drivers of this industry include an aging population, technological innovations, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Egypt Cardiac Pacemakers Market Analysis
The Egypt Cardiac Pacemakers Market was valued at $11.33 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $15.63 Mn by 2030. The key drivers of this industry include increasing incidence, aging population, and healthcare investment. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Vietnam Cardiac Pacemakers Market Analysis
The Vietnam Cardiac Pacemakers Market was valued at $20.23 Mn in 2023 and is predicted to grow at a CAGR of 3.43% from 2023 to 2030, to $25.62 Mn by 2030. The key drivers of this industry include increasing disease burden, aging population, and healthcare infrastructure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Singapore Cardiac Pacemakers Market Analysis
The Singapore Cardiac Pacemakers Market was valued at $4.86 Mn in 2023 and is predicted to grow at a CAGR of 3.8% from 2023 to 2030, to $6.31 Mn by 2030. The key drivers of this industry include increasing prevalence, healthcare expenditure, and a rising aging population. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Philippines Cardiac Pacemakers Market Analysis
The Philippines Cardiac Pacemakers Market was valued at $8.90 Mn in 2023 and is predicted to grow at a CAGR of 3.7% from 2023 to 2030, to $11.48 Mn by 2030. The key drivers of this industry include healthcare expenditure, aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Malaysia Cardiac Pacemakers Market Analysis
The Malaysia Cardiac Pacemakers Market was valued at $6.51 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $8.22 Mn by 2030. The key drivers of this industry include healthcare expenditure, aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Japan Cardiac Pacemakers Market Analysis
The Japan Cardiac Pacemakers Market was valued at $251.55 Mn in 2023 and is predicted to grow at a CAGR of 3.7% from 2023 to 2030, to $324.40 Mn by 2030. The key drivers of this industry include the aging population, healthcare infrastructure, and increased preference for minimally invasive processes. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Indonesia Cardiac Pacemakers Market Analysis
The Indonesia Cardiac Pacemakers Market was valued at $24.28 Mn in 2023 and is predicted to grow at a CAGR of 3.2% from 2023 to 2030, to $30.27 Mn by 2030. The key drivers of this industry include the growing aging population, technological advancements, and government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
China Cardiac Pacemakers Market Analysis
The China Cardiac Pacemakers Market was valued at $325.32 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $448.68 Mn by 2030. The key drivers of this industry include an increasing aging population, healthcare expenditure, and growing awareness. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
UAE Cardiac Pacemakers Market Analysis
The UAE Cardiac Pacemakers Market was valued at $20.23 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $26.99 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, advancements in technology, and government support. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Saudi Arabia Cardiac Pacemakers Market Analysis
The Saudi Arabia Cardiac Pacemakers Market was valued at $68.80 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $94.89 Mn by 2030. The key drivers of this industry include government initiatives, growing aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
UK Cardiac Pacemakers Market Analysis
The UK Cardiac Pacemakers Market was valued at $105.22 Mn in 2023 and is predicted to grow at a CAGR of 1.2% from 2023 to 2030, to $114.38 Mn by 2030. The key drivers of this industry include increasing aging population, advancements in technology, and supportive government initiatives. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Spain Cardiac Pacemakers Market Analysis
The Spain Cardiac Pacemakers Market was valued at $78.11 Mn in 2023 and is predicted to grow at a CAGR of 2.2% from 2023 to 2030, to $90.96 Mn by 2030. The key drivers of this industry include an aging population, advancements in technology, and healthcare expenditure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Germany Cardiac Pacemakers Market Analysis
The Germany Cardiac Pacemakers Market was valued at $148.12 Mn in 2023 and is predicted to grow at a CAGR of 1.4% from 2023 to 2030, to $163.26 Mn by 2030. The key drivers of this industry include the prevalence of cardiovascular disease, the aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Mexico Cardiac Pacemakers Market Analysis
The Mexico Cardiac Pacemakers Market was valued at $60.70 Mn in 2023 and is predicted to grow at a CAGR of 3.45% from 2023 to 2030, to $76.97 Mn by 2030. The key drivers of this industry include the aging population, rising chronic disease, and medical tourism. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Brazil Cardiac Pacemakers Market Analysis
The Brazil Cardiac Pacemakers Market was valued at $101.17 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $134.94 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, the aging population, and healthcare infrastructure. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.